Chen Qing-Quan, Li Dai, Guo Ren, Luo Dan, Yang Jing, Hu Chang-Ping, Li Yuan-Jian
Department of Pharmacology, School of Pharmaceutical Sciences, Central South University, Changsha 410078, China.
Eur J Pharmacol. 2008 Oct 31;596(1-3):132-7. doi: 10.1016/j.ejphar.2008.08.029. Epub 2008 Aug 30.
Calcitonin gene-related peptide (CGRP), the major transmitter in capsaicin-sensitive sensory nerves, and asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, participate in the regulation of blood pressure. In the present study, we tested the relationship between CGRP and ADMA in spontaneously hypertensive rats (SHRs). For the in vivo study, SHRs were treated with or without L-arginine for 2 weeks, and Wistar Kyoto (WKY) rats were used as controls. Systolic arterial pressure was measured, and the levels of CGRP, ADMA, and NO were analyzed. For the in vitro study, neural cells from dorsal root ganglia were treated with NO inhibitor or donor. Synthesis and release of CGRP were measured. Compared with WKY rats, serum concentration of ADMA in SHRs increased while CGRP and NO level decreased. Treatment with L-arginine significantly decreased blood pressure, concomitantly with an increase in the level of NO and the synthesis and release of CGRP in SHRs, but it did not affect ADMA levels. In cultured neural cells, ADMA reduced the level of NO and inhibited the synthesis and release of CGRP in a concentration-dependent manner. The effects of ADMA were reversed by L-arginine. Treatment with NOC-18, a donor of NO, increased the release and synthesis of CGRP in neural cells in a concentration-dependent manner. Decreased synthesis and release of CGRP is related to a reduction in NO levels, and corresponds to the increased concentrations of ADMA in spontaneously hypertensive rats.
降钙素基因相关肽(CGRP)是辣椒素敏感感觉神经中的主要递质,而不对称二甲基精氨酸(ADMA)是一氧化氮合酶的内源性抑制剂,二者均参与血压调节。在本研究中,我们检测了自发性高血压大鼠(SHR)中CGRP与ADMA之间的关系。在体内研究中,对SHR给予或不给予L-精氨酸处理2周,以Wistar Kyoto(WKY)大鼠作为对照。测量收缩动脉压,并分析CGRP、ADMA和NO的水平。在体外研究中,用NO抑制剂或供体处理背根神经节的神经细胞。检测CGRP的合成和释放。与WKY大鼠相比,SHR血清中ADMA浓度升高,而CGRP和NO水平降低。L-精氨酸治疗可显著降低血压,同时使SHR中NO水平升高以及CGRP的合成和释放增加,但不影响ADMA水平。在培养的神经细胞中,ADMA以浓度依赖的方式降低NO水平并抑制CGRP的合成和释放。L-精氨酸可逆转ADMA的作用。用NO供体NOC-18处理可使神经细胞中CGRP的释放和合成以浓度依赖的方式增加。CGRP合成和释放减少与NO水平降低有关,且与自发性高血压大鼠中ADMA浓度升高一致。